Fouty- Vaccines Flashcards
2 contributions that decreased infection rate worldwide
clean drinking water
vaccines
taking a part of small pox vesicle and innoculating another person to have milder infection and develop antibodies
Variolation
_____ was developed to try to decrease prevalence of small pox
Variolation
people were inoculated w/ ______ that produced a mild vesicular disease and recovered quickly and protected against small pox
cow pox
in 1800-1900, smallpox vaccine changed from cowpox to ______ virus
vaccinia
in 1980, what was eradicated
smallpox
SQ injections containing minced dessicated _____-infected rabbit spinal cords to patient bitten by _____-infected dog
rabies
in 1891, ____ outbreak in berlin “the strangling angel of children”
Diphtheria
Toxin from the bacteria that causes widespread multi organ failure; toxin inhibits protein synthesis
toxin from Corynebacterium diphtjeriae
in 1880s, serum from animal given ____–inactivated diphtheria toxin protected an unimmunized animal that was given virulent toxin
heat-inactivated
In 1891 Emil von Behring used animal immune serum to treat a child with _____
diphtheria
inactivated (dead) virus used to treat this
rabies
passive immunization (antibody therapy) used to treat this
diphtheria
the individual receives protective (neutralizing) antibodies from other sources
passive immunity
natural method of passive immunity
maternal antibodies
____ immunity is time dependent
passive
4 different types of products for passive immunity to infectious diseases/toxins
IVIG
hyperimmunoglobulins
animal-derived immunoglobulins
monoclonal Ab’s
the individual develops their own immune response against a pathogen due to either infection or vaccination
active immunity
____ work by inducing cells and molecules to rapidly control pathogens or inactivate toxins
vaccines
initiation of vaccine response:
antigen/adjuvant stimulates innate immune response; DC’s link innate to adaptive
APC’s that present antigen by MHC-I interact with what cell
CD8 T cell
APC’s that present antigen by MHC-II interact with what cell
CD4 T cell
CD4 (Th1) cell drives what response
adaptive immune response by CD8 T cells
CD4 (Th2) cell drives what response
humoral immune response (production of antibodies)
_____ are the key for most vaccines or infection
antibodies
_____ antigen exposure gives you higher titer volume and specific antibodies
booster antigen exposure
____ are critical to the induction of high affinity antibodies and immune memory
T cells
Neutralizing viral replication by blocking cell adhesion and entry
Binding to enzymatic active sites or preventing diffusion of toxins
Promoting opsonization/phagocytosis of bacteria
Activating complement
how antibodies prevent/reduce infection
3 main classics for vaccines
killed
live attenuated
toxoid
vaccine that caused smallpox to be eradicated
live attenuated vaccine
nasal spray for influenza A is what kind of vaccine
live-attenuated
small pox
MMR
MCG
Varicella
live attenuated vaccines
how is the virus in killed viral vaccines inactivated
formaldehyde
Rabies
Polio
Influenza A
Hep A
killed vaccine
how toxoid vaccines are made
purify toxin
inactivate it with formalin
toxoid
Diphtheria
Tetanus
toxoid vaccines
2 types of vaccines for S. pneumoniae
Polysaccharide
polysaccharide-protein conjugate
more effective against invasive disease in children
polysaccharide-protein conjugate vaccine
Bacterial DNA and plasmid DNA —- recombinant DNA w/ ______antigen producing gene
Hep B
Hep B
Anthrax
recombinant protein vaccines
HPV
Rotavirus
virus-like particle vaccine
all 6 vaccine platforms are used in the first _____ months of life
9
people can have reactions to _____ and _____ of vaccines
ingredients and byproducts
disease caused by intracellular organisms are _____ to target with vaccines
difficult
examples of intracellular organisms that are difficult to target with vaccines
Malaria
M. tuberculosis
HIV
newer vaccines used to combat COVID
nucleic (DNA and RNA) vaccines
almost all current vaccines (before COVID) were _____ or _____ based
protein or polysaccharide based
______ vaccines are based on nucleic acids, not polypeptides or polysaccharides
DNA/RNA
_____ do not generate an adaptive immune response (they generate an innate immune response)
nucleic acids (DNA/RNA)
_____ generated from nucleic acids are what induce adaptive immune response
polypeptides
protein vaccines made from
polypeptides
mRNA vaccines made from
mRNA (translation), polypeptide
DNA vaccines made from
DNA (transcription), mRNA (translation), polypeptide
_____ vaccines are based on recombinant DNA technology
nucleic acid vaccines
____ vaccines induce both B and T cell response
nucleic acid
____vaccines require transcription before translation, wheres mRNA vaccines do not
DNA
a lot of safety concerns when dealing with ______ vaccines
live attenuated
in 1990, the first mRNA tested in animals, but what was the problem
difficulty introducing mRNA into cells
in 2005, what was replaced with Uridine that helped get mRNA into cells
pseudouridine
problem in the 1990’s with exogenous RNA: innate immune response was activated and ______ the RNA
destroying
______ was the lipid used to get mRNA into cells that didn’t activate innate immune response
Lipofectin
significantly less innate immune activation when RNA was extracted from _____ cells
mammalian
Some Types Of RNA (In Vitro/Mito/Bacterial) Activate Dendritic Cells, Whereas Most Mammalian _____ Does Not
RNA
RNA ______ had no TNFa release
in vitro
Modifying RNA Nucleosides Decreased Activation Of Innate Immunity By RNA Transcribed _______
in vitro
purifying in vitro transcribed RNA using _____ decreased activation of innate immune system and improved protein translation in 2011
HPLC
ability to generate profound immunity and antibody production by purified _____
HPLC (purified lipofectin)
what improved mRNA entry into cells in 2013
development of lipid nanoparticle delivery (LNP)
using pseudouridine coupled with ____ yields the highest protein expression
LNP
_____ identified as a functional receptor for SARS COVID
ACE2
______ identified as key receptor for SARS entry into cells in 2011
TMPRSS2 (serine protease)
SARS/MERS spike protein in the _____ configuration is more immunogenic than when it is in the _____ configuration
pre-fusion; post-fusion
adding extra _____ to the hinge region of the spike protein stabilized the pre-fusion configuration
prolines
the SARS-CoV-2 sequence was published by chinese scientists on ______
january 10th 2020
the DNA template for the Moderna vaccine was generated within ____ hours of SARS-CoV-2 sequence being published
72 hours
Phe to ____ made mRNA translate much more easily
Leu
mRNA vaccine was synthesized using modified _____
uridine (pseudouridine)
COVID vaccine incorporated 2 ______ to stabilize the translated spike protein in the pre-fusion state
prolines
DNA template was synthesized and mRNA transcribed using pseudouridine and ____ and ____
purified HPLC and LNP
Moderna vaccine manufactured ____ days after SARS-CoV-2 sequence was published
25
moderna vaccine shipped to clinic ___ days after SARS-CoV-2 sequence was published
42
what 3 things lock mRNA in pre-fusion conformation
LNP, pseudouridine, proline
_____ decreases infection and sequalae in non-controlled settings in 2021
vaccine
____ and ____ developed the COVID-19 vaccine
Weisman and Kariko